Position in NUVB
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$751,214
+$180,366 QoQ
Shares Held
132,256
-0.6% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#95
of 242 holders
Holding Since
Jun 2022
11 quarters on record
Voting authority
Sole 81%
Shared 0%
None 19%
Common Shares in NUVB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Meridian Wealth Management, LLC holds $7,258,442 across 7 Biotechnology names. NUVB ranks #2 (10.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AXSM |
Axsome Therapeutics, Inc.
|
22,028 | $5,391,793 | |
| 2 | NUVB |
Nuvation Bio Inc.
This page
|
132,256 | $751,214 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
742 | $368,573 | |
| 4 | DMAC |
DiaMedica Therapeutics Inc.
|
43,600 | $306,944 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
801 | $253,188 | |
| 6 | NMRA |
Neumora Therapeutics, Inc.
|
94,400 | $160,480 | |
| 7 | BYSI |
BeyondSpring Inc.
|
15,000 | $26,250 |
All Filings in NUVB
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $751,214 | 132,256 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $570,848 | 133,065 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $1,017,542 | 113,565 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $404,650 | 109,365 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $169,874 | 87,115 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $144,909 | 82,335 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $225,674 | 84,840 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $189,703 | 82,840 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $164,527 | 56,345 | Shares | Sole | 2024-08-08 | |
| 2022-09-30 | $26,544 | 11,850 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $33,615 | 10,375 | Shares | Sole | 2022-08-05 | |
| No filing history on record for this holder in this stock. | ||||||